摘要
为了探讨B超引导下穿刺注射化疗药物与无水乙醇联合治疗肝癌的可行性及疗效,对52例肝癌患者行B超引导下穿刺注射化疗药物与无水乙醇联合治疗,均给予2个周期治疗。结果示52例患者中CR8例,彩色超声显示瘤内无彩色血流,AFP降至正常,穿刺活组织检查无肿瘤细胞残留;PR20例,活组织检查有少量肿瘤细胞残留,但AFP降至正常;NC16例。初步研究结果提示,B超引导下穿刺注射化疗药物与无水乙醇联合治疗肝癌方法简便、安全、疗效满意,是一种较为理想的治疗方法。
In order to explore the possibility and therapeutic effect of B-ultrasonic guided percutaneous intrahepatic injection of chemotherapeutics and absolute alcohol, all the 52 patients of liver cancer were treated by the injection of chemotherapeutics and absolute alcohol guided by B-ultrasonic for two cycles. Eight patients had complete remission with no intratumor colour blood flow detected by color ultrasonic, AFP dropping to normal level and no tumor cells residual detected by puncturation biopsy. There were 20 patients showed few tumor cells residual by puncturation biopsy, but AFP dropped to normal level. There were 16 patients without change. In conclusion, the percutaneous injection of chemotherapeutics and absolute alcohol guided by B-ultrasonic is a safe, convenient and relatively ideal therapy method to treat liver cancer with satisfying therapeutic effect.
出处
《中华肿瘤防治杂志》
CAS
2007年第15期1178-1179,共2页
Chinese Journal of Cancer Prevention and Treatment
基金
河北省科技厅立项课题(052761423)
关键词
肝肿瘤/药物疗法
抗肿瘤联合化疗方案/治疗应用
综合疗法
liver neoplasms/drug therapy
antineoplasmtic combined chemotherapy protocols/therapeutic uses
combined
